Category Archives: ADCETRIS

Clay Siegall’s Contribution in the Fight against Cancer

Clay Siegall is the founder and CEO of Seattle Genetics. Based in Seattle, the firm specializes in the development of therapeutic drugs for cancer treatment. Dr. Siegall founded the company in 1998 and over the years has a significant contribution to the development of drugs for cancer treatment. He developed the first FDA approved drug, Conjugate, which is now found in a variety of indications. Under Dr. Siegall, Seattle Genetics has developed a robust pipeline of various therapeutic antibody-based medicines and forged partnerships with other drug manufacturers such as Pfizer, Bayer, and Genentech.

Clay Siegall became interested in cancer treatment while studying zoology at the University of Maryland. His father got ill and had to undergo rigorous treatment and at some point almost died from anemia, which was brought about by the chemotherapy. Watching the progression of the disease at such a young age made him aware of the limited cancer options available. Siegall had always been interested in medicine and using technology to intervene in the course of nature to alleviate suffering and restore good health to the afflicted.

Since the inception of Seattle Genetics, the company has managed to secure more than $675 million capital through its Initial Public Offering in 2001 and Public and Private Financing activities. Dr. Siegall also serves on the Board of Directors of Alder Biopharmaceuticals and has authored more than 70 publications. He has experience from his tenure at the National Cancer Institute and National Institute of Health (1988-1991) as well as Bristol Myers Squibb Pharmaceuticals (1991-1997). Clay also holds 15 patents for his various developments.

Dr. Siegall believes in collaborating with other industry leaders to develop the best solutions for cancer treatment using the most advanced technological tools available. Seattle Genetics has become a leader in developing antibody drugs with a global brand, ADCETRIS that is available in more than 65 countries worldwide. Clay Siegall has received numerous awards such as the 2013 University of Maryland Alumnus of the year for Computer, Math and Natural Sciences. He also received the 2012 Pacific Northwest Ernst & Young Entrepreneur of the year award. Besides his B.S in Zoology from the University of Maryland, Dr. Siegall holds a Ph.D. in Genetics from George Washington University.